Liguo Zhu
- Hepatology top 5%
- Hepatitis C virus research 13
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research 17
- COVID-19 Clinical Research Studies 11
- SARS-CoV-2 detection and testing 7
- Viral gastroenteritis research and epidemiology 5
- Modeling and Simulation top 10%
- COVID-19 epidemiological studies 5
-
- Hepatitis B Virus Studies 17
- Liver Disease Diagnosis and Treatment 10
- Journals
- PLoS ONE (2 papers)Frontiers in Immunology (2 papers)International Journal of Epidemiology (1 paper)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Liguo Zhu
48 papers receiving 548 citations
Peers
Comparison fields: 5 of 90
- Hepatology 121
- Infectious Diseases 229
- Modeling and Simulation 29
- Epidemiology 191
- Cancer Research 81
Countries citing papers authored by Liguo Zhu
This map shows the geographic impact of Liguo Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liguo Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liguo Zhu more than expected).
Fields of papers citing papers by Liguo Zhu
This network shows the impact of papers produced by Liguo Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liguo Zhu. The network helps show where Liguo Zhu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Liguo Zhu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 0 | |
| 8 | 2023 | 2 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 5 | |
| 11 | 2023 | 2 | |
| 12 | 2021 | 6 | |
| 13 | 2020 | 14 | |
| 14 | 2020 | 54 | |
| 15 | 2019 | 34 | |
| 16 | 2017 | 24 | |
| 17 | 2016 | 4 | |
| 18 | 2015 | 8 | |
| 19 | [Rate of infection and related risk factors on hepatitis C virus in three counties of Jiangsu province]. | 2014 | 4 |
| 20 | 2013 | 40 |
About Liguo Zhu
Liguo Zhu is a scholar working on Hepatology, Infectious Diseases and Modeling and Simulation, having authored 54 papers that have together received 553 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (17 papers), Hepatitis B Virus Studies (17 papers), Hepatitis C virus research (13 papers), COVID-19 Clinical Research Studies (11 papers), Liver Disease Diagnosis and Treatment (10 papers), SARS-CoV-2 detection and testing (7 papers), Viral gastroenteritis research and epidemiology (5 papers) and COVID-19 epidemiological studies (5 papers). The work is most often cited by research in Hepatology (121 citations), Infectious Diseases (229 citations) and Modeling and Simulation (29 citations). Liguo Zhu has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Xiangjun Zhai, Zhibin Hu, Hui Jin, Fengcai Zhu, Hongbing Shen, Ci Song, Ji‐Bin Liu, Changjun Bao, Juan Wen and Jie Jiang. Their work appears in journals such as PLoS ONE, Frontiers in Immunology and International Journal of Epidemiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.